The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Insulin Delivery Systems-Global Market Insights and Sales Trends 2024
Synopsis
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries), a disposable reservoir for insulin (inside the pump) and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula.
The global Insulin Delivery Systems market size is expected to reach US$ 19310 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Delivery Systems in various end use industries. The expanding demands from the Homecare and Hospitals & Clinics, are propelling Insulin Delivery Systems market. Insulin Pens, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Pumps segment is estimated at % CAGR for the next seven-year period.
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Delivery Systems covered in this report include Becton, Dickinson and Company, Novo Nordisk, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed Holding, Animas Corporation, Tandem Diabetes Care and Insulet Corporation, etc.
The global Insulin Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Global Insulin Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Delivery Systems market, Segment by Type:
Insulin Pens
Insulin Pumps
Insulin Syringes
Global Insulin Delivery Systems market, by Application
Homecare
Hospitals & Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Delivery Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries), a disposable reservoir for insulin (inside the pump) and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula.
The global Insulin Delivery Systems market size is expected to reach US$ 19310 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Delivery Systems in various end use industries. The expanding demands from the Homecare and Hospitals & Clinics, are propelling Insulin Delivery Systems market. Insulin Pens, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Pumps segment is estimated at % CAGR for the next seven-year period.
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Delivery Systems covered in this report include Becton, Dickinson and Company, Novo Nordisk, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed Holding, Animas Corporation, Tandem Diabetes Care and Insulet Corporation, etc.
The global Insulin Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Global Insulin Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Delivery Systems market, Segment by Type:
Insulin Pens
Insulin Pumps
Insulin Syringes
Global Insulin Delivery Systems market, by Application
Homecare
Hospitals & Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Delivery Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Insulin Delivery Systems Market Overview
1.1 Insulin Delivery Systems Product Overview
1.2 Insulin Delivery Systems Market Segment by Type
1.2.1 Insulin Pens
1.2.2 Insulin Pumps
1.2.3 Insulin Syringes
1.3 Global Insulin Delivery Systems Market Size by Type
1.3.1 Global Insulin Delivery Systems Market Size Overview by Type (2018-2029)
1.3.2 Global Insulin Delivery Systems Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insulin Delivery Systems Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insulin Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insulin Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insulin Delivery Systems Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insulin Delivery Systems Sales Breakdown by Type (2018-2023)
2 Global Insulin Delivery Systems Market Competition by Company
2.1 Global Top Players by Insulin Delivery Systems Sales (2018-2023)
2.2 Global Top Players by Insulin Delivery Systems Revenue (2018-2023)
2.3 Global Top Players by Insulin Delivery Systems Price (2018-2023)
2.4 Global Top Manufacturers Insulin Delivery Systems Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Delivery Systems Market Competitive Situation and Trends
2.5.1 Insulin Delivery Systems Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Delivery Systems Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Delivery Systems as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Delivery Systems Market
2.8 Key Manufacturers Insulin Delivery Systems Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Delivery Systems Status and Outlook by Region
3.1 Global Insulin Delivery Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insulin Delivery Systems Historic Market Size by Region
3.2.1 Global Insulin Delivery Systems Sales in Volume by Region (2018-2023)
3.2.2 Global Insulin Delivery Systems Sales in Value by Region (2018-2023)
3.2.3 Global Insulin Delivery Systems Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insulin Delivery Systems Forecasted Market Size by Region
3.3.1 Global Insulin Delivery Systems Sales in Volume by Region (2024-2029)
3.3.2 Global Insulin Delivery Systems Sales in Value by Region (2024-2029)
3.3.3 Global Insulin Delivery Systems Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insulin Delivery Systems by Application
4.1 Insulin Delivery Systems Market Segment by Application
4.1.1 Homecare
4.1.2 Hospitals & Clinics
4.2 Global Insulin Delivery Systems Market Size by Application
4.2.1 Global Insulin Delivery Systems Market Size Overview by Application (2018-2029)
4.2.2 Global Insulin Delivery Systems Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insulin Delivery Systems Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insulin Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insulin Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insulin Delivery Systems Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insulin Delivery Systems Sales Breakdown by Application (2018-2023)
5 North America Insulin Delivery Systems by Country
5.1 North America Insulin Delivery Systems Historic Market Size by Country
5.1.1 North America Insulin Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insulin Delivery Systems Sales in Volume by Country (2018-2023)
5.1.3 North America Insulin Delivery Systems Sales in Value by Country (2018-2023)
5.2 North America Insulin Delivery Systems Forecasted Market Size by Country
5.2.1 North America Insulin Delivery Systems Sales in Volume by Country (2024-2029)
5.2.2 North America Insulin Delivery Systems Sales in Value by Country (2024-2029)
6 Europe Insulin Delivery Systems by Country
6.1 Europe Insulin Delivery Systems Historic Market Size by Country
6.1.1 Europe Insulin Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insulin Delivery Systems Sales in Volume by Country (2018-2023)
6.1.3 Europe Insulin Delivery Systems Sales in Value by Country (2018-2023)
6.2 Europe Insulin Delivery Systems Forecasted Market Size by Country
6.2.1 Europe Insulin Delivery Systems Sales in Volume by Country (2024-2029)
6.2.2 Europe Insulin Delivery Systems Sales in Value by Country (2024-2029)
7 Asia-Pacific Insulin Delivery Systems by Region
7.1 Asia-Pacific Insulin Delivery Systems Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Delivery Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insulin Delivery Systems Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insulin Delivery Systems Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insulin Delivery Systems Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Delivery Systems Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insulin Delivery Systems Sales in Value by Region (2024-2029)
8 Latin America Insulin Delivery Systems by Country
8.1 Latin America Insulin Delivery Systems Historic Market Size by Country
8.1.1 Latin America Insulin Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insulin Delivery Systems Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insulin Delivery Systems Sales in Value by Country (2018-2023)
8.2 Latin America Insulin Delivery Systems Forecasted Market Size by Country
8.2.1 Latin America Insulin Delivery Systems Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insulin Delivery Systems Sales in Value by Country (2024-2029)
9 Middle East and Africa Insulin Delivery Systems by Country
9.1 Middle East and Africa Insulin Delivery Systems Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Delivery Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insulin Delivery Systems Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insulin Delivery Systems Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insulin Delivery Systems Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Delivery Systems Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insulin Delivery Systems Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Becton, Dickinson and Company
10.1.1 Becton, Dickinson and Company Company Information
10.1.2 Becton, Dickinson and Company Introduction and Business Overview
10.1.3 Becton, Dickinson and Company Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Becton, Dickinson and Company Insulin Delivery Systems Products Offered
10.1.5 Becton, Dickinson and Company Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Information
10.2.2 Novo Nordisk Introduction and Business Overview
10.2.3 Novo Nordisk Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novo Nordisk Insulin Delivery Systems Products Offered
10.2.5 Novo Nordisk Recent Development
10.3 Medtronic
10.3.1 Medtronic Company Information
10.3.2 Medtronic Introduction and Business Overview
10.3.3 Medtronic Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Medtronic Insulin Delivery Systems Products Offered
10.3.5 Medtronic Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Insulin Delivery Systems Products Offered
10.4.5 Sanofi Recent Development
10.5 ELI Lilly and Company
10.5.1 ELI Lilly and Company Company Information
10.5.2 ELI Lilly and Company Introduction and Business Overview
10.5.3 ELI Lilly and Company Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.5.4 ELI Lilly and Company Insulin Delivery Systems Products Offered
10.5.5 ELI Lilly and Company Recent Development
10.6 Ypsomed Holding
10.6.1 Ypsomed Holding Company Information
10.6.2 Ypsomed Holding Introduction and Business Overview
10.6.3 Ypsomed Holding Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ypsomed Holding Insulin Delivery Systems Products Offered
10.6.5 Ypsomed Holding Recent Development
10.7 Animas Corporation
10.7.1 Animas Corporation Company Information
10.7.2 Animas Corporation Introduction and Business Overview
10.7.3 Animas Corporation Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Animas Corporation Insulin Delivery Systems Products Offered
10.7.5 Animas Corporation Recent Development
10.8 Tandem Diabetes Care
10.8.1 Tandem Diabetes Care Company Information
10.8.2 Tandem Diabetes Care Introduction and Business Overview
10.8.3 Tandem Diabetes Care Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Tandem Diabetes Care Insulin Delivery Systems Products Offered
10.8.5 Tandem Diabetes Care Recent Development
10.9 Insulet Corporation
10.9.1 Insulet Corporation Company Information
10.9.2 Insulet Corporation Introduction and Business Overview
10.9.3 Insulet Corporation Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Insulet Corporation Insulin Delivery Systems Products Offered
10.9.5 Insulet Corporation Recent Development
10.10 Biocon
10.10.1 Biocon Company Information
10.10.2 Biocon Introduction and Business Overview
10.10.3 Biocon Insulin Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Biocon Insulin Delivery Systems Products Offered
10.10.5 Biocon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Delivery Systems Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Delivery Systems Industrial Chain Analysis
11.4 Insulin Delivery Systems Market Dynamics
11.4.1 Insulin Delivery Systems Industry Trends
11.4.2 Insulin Delivery Systems Market Drivers
11.4.3 Insulin Delivery Systems Market Challenges
11.4.4 Insulin Delivery Systems Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Delivery Systems Distributors
12.3 Insulin Delivery Systems Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
